Literature DB >> 12875804

Effects of misattribution in assigning cause of death on prostate cancer mortality rates.

Richard M Hoffman1, S Noell Stone, William C Hunt, Charles R Key, Frank D Gilliland.   

Abstract

PURPOSE: Estimate the magnitude of misattribution in death certification and to determine whether misattribution could explain temporal trends in New Mexico prostate cancer mortality.
METHODS: Investigators retrospectively reviewed medical records to classify cause of death for men with prostate cancer who died in New Mexico in either 1985 or 1995. The investigator-assigned cause of death, either prostate cancer or another cause, was compared with the New Mexico Bureau of Vital Statistics' (BVS) assignment. Net misattribution was the difference between BVS and investigators in the number of deaths attributed to prostate cancer relative to the number attributed by investigators.
RESULTS: Concordance for death certification between BVS and investigators was higher in 1995 (95.8%) than 1985 (85.1%), p <0.01, but net misattribution was higher in 1995 (16.8% vs. 1.9%). During this time, the crude prostate cancer mortality rate in New Mexico increased 33.5%, from 18.5 to 24.7 per 100,000. However, after adjusting for misattribution, mortality increased only 15.9%, from 18.2 to 21.1 per 100,000.
CONCLUSIONS: Net misattribution in death certification was higher in 1995 than 1985. The adjusted increase in crude mortality rates was substantially less than the observed increase, suggesting that misattribution explained about half of the observed increase.

Entities:  

Mesh:

Year:  2003        PMID: 12875804     DOI: 10.1016/s1047-2797(02)00439-8

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  10 in total

1.  Should cause of death from the death certificate be used to examine cancer-specific survival? A study of patients with distant stage disease.

Authors:  Jennifer L Lund; Linda C Harlan; K Robin Yabroff; Joan L Warren
Journal:  Cancer Invest       Date:  2010-08       Impact factor: 2.176

2.  Prostate cancer: should men with metastases undergo radical prostatectomy?

Authors:  Drew Moghanaki; Mitchell S Anscher
Journal:  Nat Rev Urol       Date:  2013-07-16       Impact factor: 14.432

3.  Semiparametric estimation in the proportional hazard model accounting for a misclassified cause of failure.

Authors:  Jinkyung Ha; Alexander Tsodikov
Journal:  Biometrics       Date:  2015-06-23       Impact factor: 2.571

4.  Assessing the impact of screening colonoscopy on mortality in the medicare population.

Authors:  Cary P Gross; Pamela R Soulos; Joseph S Ross; Laura D Cramer; Christopher Guerrero; Mary E Tinetti; R Scott Braithwaite
Journal:  J Gen Intern Med       Date:  2011-08-13       Impact factor: 5.128

5.  Isotonic estimation of survival under a misattribution of cause of death.

Authors:  Jinkyung Ha; Alexander Tsodikov
Journal:  Lifetime Data Anal       Date:  2011-11-18       Impact factor: 1.588

6.  Death certificates provide an adequate source of cause of death information when evaluating lung cancer mortality: an example from the Mayo Lung Project.

Authors:  V Paul Doria-Rose; Pamela M Marcus
Journal:  Lung Cancer       Date:  2008-06-30       Impact factor: 5.705

7.  Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity.

Authors:  Kenneth G Nepple; Andrew J Stephenson; Dorina Kallogjeri; Jeff Michalski; Robert L Grubb; Seth A Strope; Jennifer Haslag-Minoff; Jay F Piccirillo; Jay P Ciezki; Eric A Klein; Chandana A Reddy; Changhong Yu; Michael W Kattan; Adam S Kibel
Journal:  Eur Urol       Date:  2013-03-13       Impact factor: 20.096

8.  Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975-2004.

Authors:  Sabina Hussain; David Gunnell; Jenny Donovan; Sean McPhail; Freddie Hamdy; David Neal; Peter Albertsen; Julia Verne; Peter Stephens; Caroline Trotter; Richard M Martin
Journal:  BJU Int       Date:  2008-01-10       Impact factor: 5.588

9.  Are we missing opioid-related deaths among people with HIV?

Authors:  William C Becker; Kirsha S Gordon; E Jennifer Edelman; Joseph L Goulet; Robert D Kerns; Brandon D L Marshall; David A Fiellin; Amy C Justice; Janet P Tate
Journal:  Drug Alcohol Depend       Date:  2020-04-25       Impact factor: 4.852

10.  Different spatial pattern of municipal prostate cancer mortality in younger men in Spain.

Authors:  Lara Rodriguez-Sanchez; Pablo Fernández-Navarro; Gonzalo López-Abente; Olivier Nuñez; Nerea Fernández de Larrea-Baz; Jose Juan Jimenez-Moleón; Álvaro Páez Borda; Marina Pollán; Beatriz Perez-Gomez
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.